共 40 条
[1]
Pollare, Lithell, Berne, Insulin resistance is a characteristic feature of primary hypertension independent of obesity, Metabolism, 39, pp. 167-174, (1990)
[2]
Ferranini, Buzzigoli, Bonadonna, Et al., Insulin resistance in essential hypertension, New England Journal of Medicine, 317, pp. 350-357, (1987)
[3]
Defronzo, Insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Curr Opin Cardiol, 5, pp. 586-593, (1990)
[4]
Reaven, Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease, Am Heart J, 121, pp. 1283-1289, (1991)
[5]
Rocchini, Insulin resistance and blood pressure regulation in obese and nonobese subjects, Hypertension, 17, pp. 837-842, (1991)
[6]
De Quatro, Chan, Raised plasma catecholamines in some patients with primary hypertension, Lancet, 1, pp. 806-809, (1972)
[7]
Franco-Morselli, Elghozi, Joly, Et al., Increased plasma adrenaline concentrations in benign essential hypertension, Br Med J, 2, pp. 1251-1254, (1977)
[8]
Kjeldsen, Flaaten, Leren, Et al., Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension, Scand J Clin Lab Invest, 42, pp. 217-223, (1982)
[9]
Sherwin, Sacca, Effect of epinephrine on glucose metabolism in humans: contribution of the liver, Am J Physiol, 247, pp. E157-E165, (1984)
[10]
Rizza, Haymond, Cryer, Et al., Differential effects of epinephrine on glucose production and disposal in man, Am J Physiol, 237, pp. E356-E362, (1979)